Cargando…
Adherence to a treat-to-target strategy in early rheumatoid arthritis: results of the DREAM remission induction cohort
INTRODUCTION: Clinical trials have demonstrated that treatment-to-target (T2T) is effective in achieving remission in early rheumatoid arthritis (RA). However, the concept of T2T has not been fully implemented yet and the question is whether a T2T strategy is feasible in daily clinical practice. The...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3674614/ https://www.ncbi.nlm.nih.gov/pubmed/23176083 http://dx.doi.org/10.1186/ar4099 |
_version_ | 1782272392010137600 |
---|---|
author | Vermeer, Marloes Kuper, Hillechiena H Bernelot Moens, Hein J Hoekstra, Monique Posthumus, Marcel D van Riel, Piet LCM van de Laar, Mart AFJ |
author_facet | Vermeer, Marloes Kuper, Hillechiena H Bernelot Moens, Hein J Hoekstra, Monique Posthumus, Marcel D van Riel, Piet LCM van de Laar, Mart AFJ |
author_sort | Vermeer, Marloes |
collection | PubMed |
description | INTRODUCTION: Clinical trials have demonstrated that treatment-to-target (T2T) is effective in achieving remission in early rheumatoid arthritis (RA). However, the concept of T2T has not been fully implemented yet and the question is whether a T2T strategy is feasible in daily clinical practice. The objective of the study was to evaluate the adherence to a T2T strategy aiming at remission (Disease Activity Score in 28 joints (DAS28) < 2.6) in early RA in daily practice. The recommendations regarding T2T included regular assessment of the DAS28 and advice regarding DAS28-driven treatment adjustments. METHODS: A medical chart review was performed among a random sample of 100 RA patients of the DREAM remission induction cohort. At all scheduled visits, it was determined whether the clinical decisions were compliant to the T2T recommendations. RESULTS: The 100 patients contributed to a total of 1,115 visits. The DAS28 was available in 97.9% (1,092/1,115) of the visits, of which the DAS28 was assessed at a frequency of at least every three months in 88.3% (964/1,092). Adherence to the treatment advice was observed in 69.3% (757/1,092) of the visits. In case of non-adherence when remission was present (19.5%, 108/553), most frequently medication was tapered off or discontinued when it should have been continued (7.2%, 40/553) or treatment was continued when it should have been tapered off or discontinued (6.2%, 34/553). In case of non-adherence when remission was absent (42.1%, 227/539), most frequently medication was not intensified when an intensification step should have been taken (34.9%, 188/539). The main reason for non-adherence was discordance between disease activity status according to the rheumatologist and DAS28. CONCLUSIONS: The recommendations regarding T2T were successfully implemented and high adherence was observed. This demonstrates that a T2T strategy is feasible in RA in daily clinical practice. |
format | Online Article Text |
id | pubmed-3674614 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-36746142013-06-10 Adherence to a treat-to-target strategy in early rheumatoid arthritis: results of the DREAM remission induction cohort Vermeer, Marloes Kuper, Hillechiena H Bernelot Moens, Hein J Hoekstra, Monique Posthumus, Marcel D van Riel, Piet LCM van de Laar, Mart AFJ Arthritis Res Ther Research Article INTRODUCTION: Clinical trials have demonstrated that treatment-to-target (T2T) is effective in achieving remission in early rheumatoid arthritis (RA). However, the concept of T2T has not been fully implemented yet and the question is whether a T2T strategy is feasible in daily clinical practice. The objective of the study was to evaluate the adherence to a T2T strategy aiming at remission (Disease Activity Score in 28 joints (DAS28) < 2.6) in early RA in daily practice. The recommendations regarding T2T included regular assessment of the DAS28 and advice regarding DAS28-driven treatment adjustments. METHODS: A medical chart review was performed among a random sample of 100 RA patients of the DREAM remission induction cohort. At all scheduled visits, it was determined whether the clinical decisions were compliant to the T2T recommendations. RESULTS: The 100 patients contributed to a total of 1,115 visits. The DAS28 was available in 97.9% (1,092/1,115) of the visits, of which the DAS28 was assessed at a frequency of at least every three months in 88.3% (964/1,092). Adherence to the treatment advice was observed in 69.3% (757/1,092) of the visits. In case of non-adherence when remission was present (19.5%, 108/553), most frequently medication was tapered off or discontinued when it should have been continued (7.2%, 40/553) or treatment was continued when it should have been tapered off or discontinued (6.2%, 34/553). In case of non-adherence when remission was absent (42.1%, 227/539), most frequently medication was not intensified when an intensification step should have been taken (34.9%, 188/539). The main reason for non-adherence was discordance between disease activity status according to the rheumatologist and DAS28. CONCLUSIONS: The recommendations regarding T2T were successfully implemented and high adherence was observed. This demonstrates that a T2T strategy is feasible in RA in daily clinical practice. BioMed Central 2012 2012-11-23 /pmc/articles/PMC3674614/ /pubmed/23176083 http://dx.doi.org/10.1186/ar4099 Text en Copyright ©2012 Vermeer et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Vermeer, Marloes Kuper, Hillechiena H Bernelot Moens, Hein J Hoekstra, Monique Posthumus, Marcel D van Riel, Piet LCM van de Laar, Mart AFJ Adherence to a treat-to-target strategy in early rheumatoid arthritis: results of the DREAM remission induction cohort |
title | Adherence to a treat-to-target strategy in early rheumatoid arthritis: results of the DREAM remission induction cohort |
title_full | Adherence to a treat-to-target strategy in early rheumatoid arthritis: results of the DREAM remission induction cohort |
title_fullStr | Adherence to a treat-to-target strategy in early rheumatoid arthritis: results of the DREAM remission induction cohort |
title_full_unstemmed | Adherence to a treat-to-target strategy in early rheumatoid arthritis: results of the DREAM remission induction cohort |
title_short | Adherence to a treat-to-target strategy in early rheumatoid arthritis: results of the DREAM remission induction cohort |
title_sort | adherence to a treat-to-target strategy in early rheumatoid arthritis: results of the dream remission induction cohort |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3674614/ https://www.ncbi.nlm.nih.gov/pubmed/23176083 http://dx.doi.org/10.1186/ar4099 |
work_keys_str_mv | AT vermeermarloes adherencetoatreattotargetstrategyinearlyrheumatoidarthritisresultsofthedreamremissioninductioncohort AT kuperhillechienah adherencetoatreattotargetstrategyinearlyrheumatoidarthritisresultsofthedreamremissioninductioncohort AT bernelotmoensheinj adherencetoatreattotargetstrategyinearlyrheumatoidarthritisresultsofthedreamremissioninductioncohort AT hoekstramonique adherencetoatreattotargetstrategyinearlyrheumatoidarthritisresultsofthedreamremissioninductioncohort AT posthumusmarceld adherencetoatreattotargetstrategyinearlyrheumatoidarthritisresultsofthedreamremissioninductioncohort AT vanrielpietlcm adherencetoatreattotargetstrategyinearlyrheumatoidarthritisresultsofthedreamremissioninductioncohort AT vandelaarmartafj adherencetoatreattotargetstrategyinearlyrheumatoidarthritisresultsofthedreamremissioninductioncohort |